Form 8-K - Current report:
SEC Accession No. 0001171843-25-002067
Filing Date
2025-04-07
Accepted
2025-04-07 16:50:51
Documents
13
Period of Report
2025-04-01
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_040725.htm   iXBRL 8-K 19633
  Complete submission text file 0001171843-25-002067.txt   187863

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE xbit-20250401.xsd EX-101.SCH 3014
3 XBRL LABEL FILE xbit-20250401_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE xbit-20250401_pre.xml EX-101.PRE 22358
16 EXTRACTED XBRL INSTANCE DOCUMENT f8k_040725_htm.xml XML 3407
Mailing Address 5217 WINNEBAGO LANE AUSTIN TX 78744
Business Address 5217 WINNEBAGO LANE AUSTIN TX 78744 512-386-2900
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37347 | Film No.: 25818783
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)